Finance

Lists
EPRX:TSE
Eupraxia Pharmaceuticals Inc
11,86 CA$
+1,80%
(+0,21) 1D
29 სექ, 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for EPRX...
Open
11,74 CA$
High
11,98 CA$
Low
11,53 CA$
Mkt. cap
771,12 მლნ.
Avg. vol.
74,05 ათ.
Volume
72,11 ათ.
52-wk high
12,86 CA$
52-wk low
7,35 CA$
EPS
-1,33 CA$
Beta
1,14
Shares outstanding
65,91 მლნ.
No. of employees
49
Open
11,74 CA$
High
11,98 CA$
Low
11,53 CA$
Mkt. cap
771,12 მლნ.
Avg. vol.
74,05 ათ.
Volume
72,11 ათ.
52-wk high
12,86 CA$
52-wk low
7,35 CA$
EPS
-1,33 CA$
Beta
1,14
Shares outstanding
65,91 მლნ.
No. of employees
49
About Eupraxia Pharmaceuticals Inc
CEO-
Employees49
Founded2011
Headquartersვიქტორია, ბრიტანეთის კოლუმბია, კანადა
Sector-
Last report
11 აგვ. 2026
Fiscal period
Q2 2026
EPS / Est. (CAD)
-0,32 CA$ / -
Revenue / Est. (CAD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,42 მლნ.
7,87 მლნ.
11,17 მლნ.
12,81 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,47 მლნ.
8,30 მლნ.
4,78 მლნ.
5,30 მლნ.
Operating expense
6,88 მლნ.
16,16 მლნ.
15,96 მლნ.
18,10 მლნ.
Total operating expenses
6,88 მლნ.
16,16 მლნ.
15,96 მლნ.
18,10 მლნ.
Operating income
-6,88 მლნ.
-16,16 მლნ.
-15,96 მლნ.
-18,10 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-6,37 მლნ.
-16,71 მლნ.
-12,64 მლნ.
-14,46 მლნ.
EBT excluding unusual items
-6,37 მლნ.
-16,71 მლნ.
-12,64 მლნ.
-14,46 მლნ.
Income tax expense
-623,00
11,34 ათ.
13,90 ათ.
30,38 ათ.
Effective tax rate
0,01%
-0,07%
-0,11%
-0,21%
Other operating expenses
-
-
-
-
Net income
-6,36 მლნ.
-16,71 მლნ.
-12,65 მლნ.
-14,49 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,19
-
-
-
Interest and investment income
180,18 ათ.
666,92 ათ.
1,07 მლნ.
1,39 მლნ.
Interest expense
-
-
-
-
Net interest expenses
180,18 ათ.
666,92 ათ.
1,07 მლნ.
1,39 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,84 მლნ.
-16,11 მლნ.
-15,90 მლნ.
-18,02 მლნ.
Gain or loss from assets sale
-
1,49 ათ.
-
2,70 ათ.
AI content may include mistakes. Learn more
Google აპები